
Pharma Pulse 9/26/24: How Pharma Can Reach Sustainability Goals, Takeaways from Senate Semaglutide Pricing Hearing & more
The latest news for pharma industry insiders.
A panel discussion regarding "How Pharma Can Better Understand Its Carbon Footprint and Reach Sustainability Goals" convened yesterday, and was moderated by Joe Van Der Bosch, president of DeSpir Logistics. He was joined by Alaina Passavant, account manager, CDP Supply Chain; Kaushik Datta, a pharma supply chain expert, Chandan Trehan, digital supply chain & sustainability Lead with Bosch; Jeff Tucker, CEO, Tucker Company Worldwide, and Joe McCannon, director for sustainability at the Office of the Federal Chief Sustainability Officer, Council on Environmental Quality (CEG).
Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not impact formulary coverage.
The company cut about 25% of its pipeline, said Teresa Graham, chief of Roche’s pharma division.
In honor of World Dense Breast Day on September 25, Bayer announced today a new study, published in Patient Preference and Adherence, evaluating awareness and knowledge gaps of breast cancer risk factors among women with and without high breast density (HBD). The study, a web-based survey, found only 39 percent were familiar with the concept of HBD in the context of breast cancer, and 31 percent were aware of HBD as a Breast Cancer Risk Factor.
Thank you to Pharmaceutical Executive's Miranda Schmalfuhs for interviewing Jonathan Scheinberg about mega campuses in the life sciences sector. The Northeast Science & Technology (NEST) Center is a prime example of a repurposed mega campus, creating an innovative ecosystem for life sciences to thrive.
#LifeSciences #MegaCampus #PharmaInnovation #NEST #Biotech #RandD
 #BigPharma #FutureOfScience #NESTCenter #RealEstate #CommercialR
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

